Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338749 · ClinicalTrials.gov registry record · NA
Computer Cognitive Training for Post-acute COVID-19 Syndrome
A NA study of Cognitive Dysfunction and Corona Virus Infection, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05338749: Completed NA study of Cognitive Dysfunction and Corona Virus Infection, sponsored by Nova Southeastern University.
NCT05338749 is a NA study of Cognitive Dysfunction and Corona Virus Infection that has completed, run by Nova Southeastern University. The registered enrollment target is 16 participants, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338749, a NA study of Cognitive Dysfunction and Corona Virus Infection, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the acceptability, feasibility, and impact of game-based computer-delivered cognitive training on cognitive function in persons with cognitive symptoms that persist after recovery from acute coronavirus-19 (COVID) infection.
Primary Outcome
User self-report of their perception that an application serves a function that may be helpful The score is the average of several items rated by the user from 0 to 6, so that the final score itself can range from 0 to 6. Higher scores indicate that the user found the intervention more useful. Higher scores are better.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Training
Study Locations (1)
Florida
- Center for Collaborative Research, Nova Southeastern University - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
What the finished NCT05338749 record still lists
NCT05338749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cognitive Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Training is the first listed.
NCT05338749 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05338749 about?
NCT05338749 is a clinical study titled "Computer Cognitive Training for Post-acute COVID-19 Syndrome". This study will assess the acceptability, feasibility, and impact of game-based computer-delivered cognitive training on cognitive function in persons with cognitive symptoms that persist after recovery from acute coronavirus-19 (COVID) infection.
What is the current status of trial NCT05338749?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-04-26. Estimated completion is 2023-11-30.
What conditions does trial NCT05338749 study?
This clinical trial studies the following conditions: Cognitive Dysfunction, Corona Virus Infection.
What interventions are being tested in trial NCT05338749?
The interventions under investigation include: Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05338749?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05338749 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05338749's enrollment target sits among peer trials
16 40th of 45 higher than 6 of 45 other Cognitive Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
RECRUITING · NA
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI